Medtronic has secured the FDA’s approval for the latest generation of its miniaturized, wireless pacemaker implants, the Micra AV2 and VR2. According to the company, the newest models can offer up to ...

DUBLIN, May 1, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 ...

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

Medtronic recently unveiled its leadless pacemaker, which is still in development. Medtronic unveiled its eagerly anticipated leadless pacemaker at the TEDMED conference last week and already has ...

The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, ...